Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crispr Therapeutics Ag
(NQ:
CRSP
)
45.58
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
232
Open
45.58
Bid (Size)
45.15 (1)
Ask (Size)
45.57 (4)
Prev. Close
45.58
Today's Range
45.58 - 45.58
52wk Range
37.55 - 91.10
Shares Outstanding
78,935,098
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
September 26, 2024
Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths.
Via
Investor's Business Daily
3 Dirt Cheap Stocks to Buy Right Now
September 21, 2024
Bargain hunters should love these great stocks.
Via
The Motley Fool
Performance
YTD
-31.00%
-31.00%
1 Month
+0.13%
+0.13%
3 Month
-14.19%
-14.19%
6 Month
-29.91%
-29.91%
1 Year
+7.47%
+7.47%
More News
Read More
Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?
September 19, 2024
Via
The Motley Fool
1 Biotech Stock Down 62% to Buy and Hold
September 12, 2024
Via
The Motley Fool
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
September 12, 2024
Via
The Motley Fool
Looking for Stock Bargains With Room to Run? Try This.
September 11, 2024
Via
The Motley Fool
Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal?
September 05, 2024
Via
The Motley Fool
3 Monster Biotech Stocks to Buy Before 2025
September 02, 2024
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
August 26, 2024
Via
The Motley Fool
Got the Market Sell-Off Blues? Do These 3 Things Right Now
August 11, 2024
Via
The Motley Fool
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
August 08, 2024
Via
Benzinga
7 Biotech Stocks to Buy for Their Game-Changing Potential
August 08, 2024
Via
InvestorPlace
The 3 Best Gene Editing Stocks to Buy in August 2024
August 07, 2024
Via
InvestorPlace
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
August 06, 2024
Via
The Motley Fool
CRSP Stock Earnings: CRISPR Therapeutics Beats EPS, Misses Revenue for Q2 2024
August 05, 2024
Via
InvestorPlace
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
August 05, 2024
Via
The Motley Fool
Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker
August 04, 2024
Via
The Motley Fool
3 Unstoppable Stocks to Buy in August
August 03, 2024
Via
The Motley Fool
10 Best Small and Mid-Cap Stocks to Consider Buying in August
August 01, 2024
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
July 31, 2024
Via
The Motley Fool
The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024
July 29, 2024
Via
InvestorPlace
3 Small-Cap Stocks to Buy at a 52-Week Low
July 27, 2024
Via
InvestorPlace
3 Gene Editing Stocks Shaping the Future of Medicine
July 22, 2024
Via
InvestorPlace
3 Monster Stocks in the Making to Buy Right Now
July 20, 2024
Via
The Motley Fool
3 Gene Editing Stocks That Could Grow Your Wealth
July 17, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.